The list price for Zepbound is $1,086.37 for four pens (a monthly 28-day supply)
Clinical Data Clinical Trial Results 28.7% Average Weight Loss 68 weeks 58.6% Achieved 25%+ Loss of participants 445 Trial Participants Phase 3 Data from the Phase 3 TRIUMPH-4 trial of retatrutide, reported by Eli Lilly (topline, 2025)
sources for labeling and medication-error context
Many people make the mistake of dramatically increasing exercise when weight loss stalls
Hims & Hers said the new pill starts at $49 per month for five months, and comes with the same active ingredient as Novo Nordisk's Wegovy, which received FDA approval in December and costs $149 for self-pay patients, according to the company's website
Compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), and telehealth clinicians approve eligible patients within 24 hours of enrollment